Canadian National Railway
CNR
$0.00
+0.08%
Core Natural Resources, Inc. is a producer and exporter of metallurgical and thermal coal, operating longwall mining operations and export terminals in the Energy sector's coal industry. The company is a niche player with integrated operations from mining to export logistics, distinguishing itself through vertical integration. The current investor narrative is dominated by a stark reversal in financial performance, as recent quarterly data shows a significant shift from strong profitability in 2024 to substantial losses in 2025, driving intense debate over the sustainability of its business model amid volatile commodity prices and operational challenges.…
CNR
Canadian National Railway
$0.00
Investment Opinion: Should I buy CNR Today?
Rating: Hold. The core thesis is that CNR is a deeply troubled company trading at a distressed valuation, where the significant downside risk from ongoing operational losses is balanced by the limited further multiple compression possible and the potential for a cyclical recovery, making it unsuitable for most investors but a speculative option for turnaround specialists.
Supporting this view, the stock trades at a deeply discounted PS ratio of 1.09x, a fraction of its historical 5.55x multiple. While Q4 2025 revenue grew 82.96% YoY, this is overshadowed by catastrophic margin collapse, with gross profit turning negative. The company's negative ROE of -4.17% and net margin of -3.68% confirm it is destroying shareholder value. Analyst price targets, implied by EPS estimates, suggest a wide range of outcomes but no clear consensus upside from the current price.
The thesis would upgrade to a Buy only upon clear evidence of gross margin returning to positive territory in the next quarterly report and a sustained break above the $100 technical resistance level. It would downgrade to a Sell if revenue growth stalls or if the net loss widens further in Q1 2026. Relative to its own history, the stock is undervalued, but relative to its current fundamentals of negative profitability, it remains fairly valued or even overvalued, as it still carries a market cap of $4.55 billion despite burning cash.
Sign up to view all
CNR 12-Month Price Forecast
CNR presents a classic 'value trap' versus 'deep value turnaround' dichotomy. The neutral stance reflects the high probability (50%) base case of continued operational struggles and sideways trading. The stance would upgrade to bullish only upon concrete, multi-quarter evidence of margin recovery, specifically a return to a double-digit gross margin. It would turn bearish if the next earnings report shows further margin deterioration or a guidance withdrawal, confirming the operational issues are structural rather than cyclical.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Canadian National Railway's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
3 analysts
Implied Upside
—
vs. current price
Analyst Count
3
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, indicating this is a smaller or less-followed name which can lead to higher volatility and less efficient price discovery. The consensus sentiment is unclear from the provided data, as specific buy/hold/sell ratings and an average price target are not available; however, institutional ratings show recent actions, with firms like UBS and Jefferies maintaining or initiating 'Buy' or 'Hold' ratings in 2025 and early 2026. The target range, based on estimated EPS, is wide with a low of $6.94 and a high of $12.29, implying significant uncertainty about the company's future earnings power; the high target likely assumes a recovery in coal prices and operational efficiency, while the low target may price in continued margin pressure and losses. The pattern of institutional ratings shows consistency (e.g., UBS maintaining 'Buy'), but the wide EPS forecast range underscores the high uncertainty inherent in the company's current fundamental predicament.
Bulls vs Bears: CNR Investment Factors
The bear case currently holds stronger evidence, anchored by the catastrophic and rapid deterioration in profitability from high margins to deep losses within a year. While the bull case points to a deeply discounted valuation and strong revenue growth, the core investment debate hinges on whether the collapse in Q4 2025 margins is a temporary operational misstep or a permanent impairment of the business model. The single most important tension is the company's ability to restore positive gross margins; if it cannot, the revenue growth is meaningless, but any sign of margin recovery could trigger a powerful re-rating from today's depressed levels.
Bullish
- Deeply Discounted Valuation: The stock trades at a trailing PS ratio of 1.09x, a dramatic compression from its 5.55x multiple in Q4 2024, suggesting it is priced near the bottom of its historical valuation band. This low multiple, coupled with an EV/Sales of 1.03x, indicates the market has already priced in significant deterioration, limiting further downside if fundamentals stabilize.
- Strong Revenue Growth Trajectory: Q4 2025 revenue grew 82.96% year-over-year to $1.04 billion, demonstrating the company's ability to generate significant top-line expansion despite operational headwinds. This growth, following a period of high profitability in 2024, suggests underlying demand for its integrated coal operations remains robust.
- Solid Balance Sheet & Liquidity: The company maintains a low debt-to-equity ratio of 0.096 and a healthy current ratio of 1.60, indicating manageable leverage and adequate short-term liquidity to weather the current downturn. This financial flexibility provides a buffer against the operational cash burn, as evidenced by the -$78.98 million net loss in Q4 2025.
- Institutional Analyst Support: Despite limited coverage, institutional analysts like UBS and Jefferies have maintained or initiated 'Buy' or 'Hold' ratings in 2025/2026, signaling professional confidence in a potential recovery. The high analyst EPS target of $12.29 implies significant upside if the company can restore profitability.
Bearish
- Catastrophic Collapse in Profitability: The company swung from a net income of $30.8 million in Q4 2024 to a loss of -$78.98 million in Q4 2025, with gross margins collapsing from 76.57% to -6.83%. This indicates a severe breakdown in its cost structure and operational efficiency, raising existential questions about its business model's viability at current commodity prices.
- Severe Technical Downtrend: The stock is in a 'falling knife' scenario, trading at $82.41, just 43% above its 52-week low of $64.15 and down 8.13% over the past month. It has underperformed the SPY by -16.32% over one month, reflecting intense selling pressure and a complete reversal of its earlier 2026 gains, signaling a strong bearish momentum.
- Negative Margins and Cash Burn: Trailing operating and net margins are deeply negative at -5.19% and -3.68%, respectively, confirming the company is burning cash on core operations. With free cash flow of $21.17 million over the TTM, the cushion is thin, and sustained losses could quickly erode the balance sheet strength.
- High Fundamental Uncertainty: Analyst EPS forecasts range widely from $6.94 to $12.29, reflecting extreme uncertainty about the company's future earnings power. This, combined with the stock's low beta of 0.137, suggests it is driven by idiosyncratic, company-specific risks rather than broader market trends, making it difficult to model and value.
CNR Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of +10.11% masking a severe recent correction, as it is currently trading near the bottom of its 52-week range at 82.41, just 43% above its 52-week low of 64.15 and 28% below its high of 114.8. This positioning near recent lows suggests the stock is in a 'falling knife' scenario, having given back nearly all gains from its March 2026 peak. Recent momentum is decisively negative, with the stock down 8.13% over the past month and 8.48% over the past three months, sharply diverging from the positive 1-year trend and signaling a strong bearish reversal; this is further evidenced by a massive -16.32 relative strength versus the SPY over one month, indicating severe underperformance. Key technical support is at the 52-week low of 64.15, while resistance lies at the recent high of 114.8; a breakdown below support would signal a continuation of the downtrend, while a recovery above the 100 level is needed to suggest stabilization. With a beta of 0.137, the stock exhibits significantly lower volatility than the broader market, which historically provided defensive characteristics but has not prevented a deep drawdown of -27.22% from its peak.
Beta
0.14
0.14x market volatility
Max Drawdown
-27.2%
Largest decline past year
52-Week Range
$64-$115
Price range past year
Annual Return
+21.4%
Cumulative gain past year
| Period | CNR Return | S&P 500 |
|---|---|---|
| 1m | -6.2% | +4.4% |
| 3m | -4.4% | +8.5% |
| 6m | +8.2% | +9.7% |
| 1y | +21.4% | +28.8% |
| ytd | -6.5% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CNR Fundamental Analysis
Revenue trajectory shows dramatic volatility, with Q4 2025 revenue of $1.04 billion representing a staggering 82.96% year-over-year growth, but this masks a severe deterioration in profitability as the company swung from a net income of $30.8 million in Q4 2024 to a loss of -$78.98 million in Q4 2025. The multi-quarter trend reveals instability, with revenue in the preceding Q3 2025 at $1.00 billion and Q2 2025 at $1.10 billion, but growth is not translating to earnings, casting doubt on the underlying business model. Profitability has collapsed, with the company reporting a net loss of -$78.98 million in Q4 2025 and a gross margin of -6.83%, compared to a positive gross margin of 76.57% and net income of $30.8 million in the year-ago quarter. Margins have compressed catastrophically, as evidenced by the trailing net margin of -3.68% and operating margin of -5.19%, indicating the company is currently burning cash on its core operations with no clear path back to the high profitability seen in 2024. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.096, and a current ratio of 1.60 suggests adequate short-term liquidity. However, cash flow generation is weak, with trailing twelve-month free cash flow of $21.17 million and an ROE of -4.17%, indicating the company is not creating shareholder value from its equity base and is financially dependent, as its modest FCF may not be sufficient to fund operations if losses persist.
Quarterly Revenue
$1.0B
2025-12
Revenue YoY Growth
+0.82%
YoY Comparison
Gross Margin
-0.06%
Latest Quarter
Free Cash Flow
$21171000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CNR Overvalued?
Given the negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 1.09, while the forward valuation is implied by an EV/Sales of 1.03; the minimal gap suggests the market expects little to no sales growth or margin improvement in the near term. Compared to industry averages, specific sector multiples are not provided in the data, but a PS ratio around 1.0x is generally low and may reflect a discount for companies in cyclical or challenged industries like coal, especially given the company's negative margins. Historically, the stock's own valuation has plummeted from a PS ratio of 5.55 in Q4 2024 to the current 1.09, indicating it is trading near the bottom of its own historical valuation band. This compression reflects the market's repricing from a period of high profitability to the current state of operational losses, suggesting the stock is either a deep value opportunity if a turnaround occurs or is correctly priced for fundamental deterioration.
PE
-29.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -75x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on the company's inability to convert robust revenue growth into profits. The Q4 2025 gross margin of -6.83% and net loss of -$78.98 million represent a fundamental breakdown, indicating costs have spiraled out of control relative to sales prices. While the balance sheet shows moderate leverage (D/E of 0.096) and adequate liquidity (Current Ratio of 1.60), the trailing operating cash flow is negative, and the modest TTM FCF of $21.17 million provides a thin buffer against continued quarterly losses of this magnitude. The company is financially dependent on a swift operational turnaround.
Market & Competitive Risks are elevated due to the stock's valuation compression and sector headwinds. The PS ratio has collapsed from 5.55x to 1.09x, reflecting a massive de-rating that may not be complete if losses persist. As a coal producer, CNR is exposed to volatile global commodity prices, regulatory pressures on fossil fuels, and potential demand destruction from the energy transition. The stock's low beta of 0.137 suggests it does not benefit from broad market rallies but remains vulnerable to its own specific operational failures and negative sector sentiment.
Worst-Case Scenario involves a continuation of the current operational crisis, where negative gross margins become entrenched, leading to sustained quarterly cash burns. This could force asset sales, equity dilution, or a breach of debt covenants, eroding the balance sheet strength. The realistic downside is a retest of the 52-week low of $64.15, which represents a -22% decline from the current price of $82.41. In an extreme scenario where the company's viability is questioned, the stock could fall below this level, potentially resulting in a total loss for equity holders if the business fails.
FAQ
The key risks are, in order of severity: 1) Operational Risk: The inability to restore positive gross margins, leading to sustained cash burn (Q4 2025 gross margin: -6.83%). 2) Commodity Price Risk: Exposure to volatile metallurgical and thermal coal prices, which directly impact revenue and margins. 3) Financial Risk: While leverage is low now, prolonged losses could weaken the balance sheet and lead to dilution. 4) Sector Risk: Long-term structural decline of the coal industry due to environmental regulations and energy transition, potentially capping any recovery's magnitude.
The 12-month forecast is highly bifurcated, with a 50% probability base case target range of $80-$95, implying sideways movement from the current $82.41. The bull case (25% probability) targets $110-$125 on a successful operational turnaround, while the bear case (25% probability) sees a drop to $64-$75 if losses persist. The most likely scenario is the base case, where the company muddles through with modest improvement but fails to decisively win back investor confidence, keeping the stock range-bound. The key assumption is that margin recovery will be slow and uncertain.
CNR is fairly valued relative to its current broken fundamentals but deeply undervalued relative to its own profitable history. The trailing PS ratio of 1.09x is a massive discount to the 5.55x multiple it commanded in Q4 2024 when it was profitable. This compression reflects the market's rational repricing for negative margins and cash burn. Compared to industry peers, a ~1x PS multiple is typical for challenged commodity cyclicals. The valuation implies the market expects continued poor profitability and assigns little premium for growth until margins are restored.
CNR is not a good buy for most investors. It is a highly speculative turnaround situation with severe operational problems, evidenced by its negative gross margin of -6.83% and net loss of -$78.98 million in its latest quarter. While the valuation appears cheap at a PS ratio of 1.09x, this discount is justified by the fundamental deterioration. It could only be considered a good buy by deep-value, high-risk investors who have high conviction that management can swiftly restore profitability and who are prepared to withstand potential further downside to the 52-week low of $64.15.
CNR is unsuitable for traditional long-term 'buy and hold' investing due to its cyclical nature, operational instability, and the secular headwinds facing the coal industry. It is also a poor short-term trading vehicle due to its low beta (0.137) and susceptibility to company-specific news rather than broad market trends. The only appropriate horizon is a medium-term, event-driven speculative hold of 6-18 months, aimed at capturing a potential operational turnaround. Investors should be prepared to exit quickly if the turnaround thesis fails, as indicated by further margin deterioration.